ABOUT MRN - MEDICAL RESEARCH NETWORK
At MRN we understand the complexities of today’s clinical trial environment and the burden this places on patients, clients and sites.
Our services are designed to ease these burdens, from community researchers through to investigator site professional support, accelerating patient recruitment and retention.
We work to maximize the efficiency of clinical trials for drug developers, by improving the patient’s experience, no matter where their community is in the world.
FEATURED ARTICLES
-
Overcoming Barriers To Clinical Trial Participation In Oncology
Oncology clinical trials face unique challenges in patient recruitment and retention due to barriers such as awareness, logistical constraints, and eligibility criteria.
-
Improving Patient Access Through Home-Based Trials, Site Networks
By implementing home trial support, sponsors can improve patient access, enhance diversity, and ultimately accelerate the development of new therapies.
-
Home Trial Support: A Crucial Tool For Patient-Centered Clinical Trials
Home trial support services can play a significant role in improving patient access and engagement across a range of studies.
-
Think About The Big Picture! Delivering More Opportunities
Failing to recruit and retain patients results in 86% of all trials not meeting their enrollment deadlines and 30% of Phase III trials fail –ultimately driving up costs and risk. If we think about the big picture, we can reduce the risk of running trials while expanding trials into new communities, increasing access to trials for any patient and any sites that wants to participate. Learn how focusing on patients and sites can drive results for trials.
-
Accelerating Timelines By Bringing Clinical Trials To Patients' Communities
Accelerating overall trial timelines is critical to minimizing the financial risk of a clinical trial, and a hybrid trial model could work to speed up your recruitment and improve retention.
-
How To Build A Hybrid Visit Strategy That Delivers High-Quality Results
In-home clinical trial visits yield major benefits for patients, including increased access and convenience. As a result, hybrid trials are helping developers increase enrollment, engagement, and retention.
CONTACT INFORMATION
MRN - Medical Research Network
8001 N Lincoln Ave
Skokie, IL 60077
UNITED STATES
Phone: 847 779 7857
Contact: Laura Lange
BROCHURES
-
Home Trial Support (HTS) enables patients to participate in clinical trials from the comfort of their homes and has proven to be a successful tool for delivering care to oncology study participants.
-
Examine how allowing for patient flexibility during decentralized clinical trial visits can improve an oncology study's results while meeting legal, compliance, and quality regulations.
-
Discover how having complete visits in communities across the globe can lead to a wider diverse demographic of participants.
-
As industry experts, we've delivered innovative solutions using specialized expertise and creative approaches, providing in-home clinical trial visits through their Home Trial Support service to over 230 trials.
-
As industry experts in DCT, MRN has delivered innovative solutions using our specialized expertise and creative approaches, providing in-home clinical trial visits through their Home Trial Support service to over 230 trials.
-
By utilizing MRN's extensive experience, global network, and innovative approach, learn how they are helping to deliver efficient, cost-effective, and successful trials wherever the patients live.
-
Sites need to have the resources and expertise in place to allow decentralized clinical trials to run smoothly. Site Professional Support (SPS) service will help you and your sites function efficiently and smoothly for the duration of the study.
-
By conducting trial visits outside of the site, physicians can expand their reach, making drug development more accessible. Read about how MRN's Home Trial Support "HTS" is the engine powering DCTs.